Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China
· Delayed Price · Currency is CNY 41.19
+1.14 (2.85%)
Apr 29, 2026, 3:00 PM CST
SHA:600211 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,276 | 13,715 | 11,906 | 12,099 | 8,906 | 12,982 | Upgrade
|
| Market Cap Growth | 8.20% | 15.19% | -1.59% | 35.86% | -31.40% | -22.18% | Upgrade
|
| Enterprise Value | 11,007 | 11,801 | 9,880 | 10,369 | 7,662 | 12,467 | Upgrade
|
| Last Close Price | 41.19 | 42.55 | 35.29 | 34.33 | 24.38 | 35.22 | Upgrade
|
| PE Ratio | 14.15 | 14.62 | 11.33 | 15.11 | 24.08 | 62.13 | Upgrade
|
| Forward PE | - | 26.48 | 26.48 | 26.48 | 26.48 | 26.48 | Upgrade
|
| PS Ratio | 4.45 | 4.60 | 4.24 | 3.86 | 3.49 | 6.07 | Upgrade
|
| PB Ratio | 3.21 | 3.32 | 3.01 | 3.59 | 2.94 | 4.91 | Upgrade
|
| P/TBV Ratio | 3.89 | 4.02 | 3.20 | 3.86 | 3.44 | 5.88 | Upgrade
|
| P/FCF Ratio | 13.43 | 13.87 | 12.44 | 11.62 | 12.11 | - | Upgrade
|
| P/OCF Ratio | 13.21 | 13.65 | 11.97 | 11.38 | 10.64 | 35.42 | Upgrade
|
| EV/Sales Ratio | 3.69 | 3.96 | 3.52 | 3.31 | 3.00 | 5.83 | Upgrade
|
| EV/EBITDA Ratio | 10.97 | 11.78 | 10.20 | 9.37 | 10.12 | 19.06 | Upgrade
|
| EV/EBIT Ratio | 11.90 | 12.76 | 11.06 | 9.98 | 11.13 | 21.77 | Upgrade
|
| EV/FCF Ratio | 11.13 | 11.93 | 10.32 | 9.95 | 10.42 | - | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.20 | 0.07 | 0.15 | 0.16 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 0.84 | 0.84 | 0.28 | 0.45 | 0.64 | 0.82 | Upgrade
|
| Debt / FCF Ratio | 0.85 | 0.85 | 0.29 | 0.48 | 0.66 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.63 | -0.63 | -0.59 | -0.56 | -0.48 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.60 | -2.60 | -2.43 | -1.69 | -1.91 | -1.17 | Upgrade
|
| Net Debt / FCF Ratio | -2.64 | -2.64 | -2.46 | -1.80 | -1.96 | 12.93 | Upgrade
|
| Asset Turnover | 0.54 | 0.54 | 0.60 | 0.72 | 0.65 | 0.63 | Upgrade
|
| Inventory Turnover | 1.09 | 1.09 | 1.32 | 1.50 | 1.73 | 2.17 | Upgrade
|
| Quick Ratio | 2.67 | 2.67 | 4.40 | 2.74 | 2.51 | 1.76 | Upgrade
|
| Current Ratio | 2.83 | 2.83 | 4.66 | 2.87 | 2.64 | 1.97 | Upgrade
|
| Return on Equity (ROE) | 22.67% | 22.67% | 28.86% | 25.30% | 13.23% | 8.14% | Upgrade
|
| Return on Assets (ROA) | 10.49% | 10.49% | 11.96% | 14.95% | 10.89% | 10.61% | Upgrade
|
| Return on Invested Capital (ROIC) | 51.47% | 52.08% | 52.87% | 60.70% | 32.15% | 25.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.00% | 20.00% | 22.40% | 30.50% | 22.40% | 21.30% | Upgrade
|
| Earnings Yield | 7.06% | 6.84% | 8.83% | 6.62% | 4.15% | 1.61% | Upgrade
|
| FCF Yield | 7.45% | 7.21% | 8.04% | 8.61% | 8.26% | -0.46% | Upgrade
|
| Dividend Yield | 4.39% | 4.13% | 5.55% | 4.34% | 2.35% | 0.74% | Upgrade
|
| Payout Ratio | 65.41% | 65.41% | 47.95% | 61.74% | 26.55% | 63.41% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | 0.05% | 0.14% | -0.09% | 0.21% | -0.53% | Upgrade
|
| Total Shareholder Return | 4.40% | 4.18% | 5.69% | 4.26% | 2.56% | 0.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.